Protect your patients against 20 strains of invasive pneumococcal disease with Prevnar 20—the latest advancement in pneumococcal immunization from Pfizer. Trusted by healthcare professionals, Prevnar 20 delivers comprehensive, broad-spectrum protection for adults and children, helping prevent pneumonia, bloodstream infections, and meningitis caused by Streptococcus pneumoniae.
Product Features & Benefits
-
Broadest Pneumococcal Coverage: The only FDA-approved 20-valent conjugate vaccine, targeting 20 pneumococcal serotypes responsible for the majority of invasive infections.
-
Advanced Conjugate Technology: Utilizes Diphtheria CRM197 protein carrier to stimulate a strong, lasting immune response.
-
Trusted Manufacturer: Developed by Pfizer USPG, a global leader in vaccines and infection prevention.
-
Versatile Indications: Approved for use in adults 18+ and pediatric patients as indicated by the CDC.
-
Ready-to-Use Dosing: Available in convenient, single-dose prefilled syringes for easy administration in hospitals, clinics, and long-term care settings.
-
CDC and ACIP Recommended: Aligned with current immunization guidelines for adult and childhood pneumococcal vaccination schedules.
Top Health-Related Searched Terms:
- Prevnar 20 vaccine
- Pneumococcal conjugate vaccine
- 20-valent pneumonia vaccine
- Pneumonia prevention
- Adult immunization
- Senior vaccines
- CDC recommended vaccines
- Childhood vaccination
- Pneumonia vaccine for adults
- Pfizer vaccines
- Vaccines for seniors over 65
- Immunization for chronic disease
- Respiratory infection prevention
- FDA approved vaccine
- Travel vaccines
- Prevention of bacterial pneumonia
- Pneumococcal disease protection
- Long-term care vaccination
Why Choose Prevnar 20?
Pneumococcal infections are a leading cause of morbidity and mortality, especially in adults over 65, those with chronic diseases, and young children. Prevnar 20 offers the highest valency available in pneumococcal conjugate vaccines, increasing immunity against more serotypes than ever before.
Whether you’re aiming to fulfill the adult or senior pneumonia vaccine recommendations, protect high-risk populations from invasive Streptococcus pneumoniae infections, or support robust immunity in pediatric and immunocompromised patients, Prevnar 20 by Pfizer sets a new standard for preventive healthcare.
Administration & Dosage
-
Dosage Form: 0.5 mL intramuscular injection (single-dose vial or prefilled syringe)
-
Age Indication: Adults 18 years and older; children per CDC guidelines
-
Dosing Schedule: Single-dose for most adults; consult CDC guidelines for pediatric series or catch-up immunizations.
Safety & Side Effects
Prevnar 20 is well-tolerated, with side effects usually mild to moderate and transient. The most common include injection site pain, redness, swelling, muscle aches, fatigue, headache, and mild fever. Serious allergic reactions are rare. Consult a healthcare provider regarding medical history and potential contraindications.
Order Prevnar 20 Vaccine Today
Enhance your immunization program with Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine by Pfizer USPG—the most comprehensive pneumococcal vaccine available. Stock up and protect adults and children against the full spectrum of serious pneumococcal diseases.
Buy Prevnar 20 now for broad-spectrum protection, effective pneumonia prevention, and the latest in vaccine technology—trusted for adult, senior, and pediatric immunization worldwide.
Skip to content
